Connecting with Cardiology

Our goal is to ensure the appropriate use of diagnostics to deliver improved health outcomes, better patient experiences and more cost effective care pathways.

Early identification and management of patients with high cardiovascular risk factors can lead to improved quality of life, lower mortality and reduced costs.

The Alere cardiovascular portfolio includes diagnostic tests measuring biomarkers in a variety of point-of-care settings including the hospital emergency setting or bedside, outpatient office, GP surgery or patient home, spanning the disease continuum from risk assessment, diagnosis to ongoing monitoring.

• In the area of risk assessment, Alere offers a comprehensive lipid profile panel with tests for HDL and LDL cholesterol, triglycerides, glucose, ALT AST and hsCRP.
• Alere provides solutions for diagnosis and prognosis of heart failure, diagnosis of acute myocardial infarction, assessment and evaluation of patients suspected of having VTE events, provides a test for quantitative determination of NGAL and active in the field of PT/INR monitoring.

Alere is focused in bringing testing closer to the clinician and the patient, enabling better information, earlier intervention and more cost effective disease management.